Botulinum toxin versus submandibular duct relocation for severe drooling

Aim Botulinum neurotoxin type A (BoNT‐A) has been described as an effective intervention for drooling and is being increasingly adopted. However, its effectiveness compared with established treatments is still unknown. We undertook a within‐participants observational study to examine this. Method ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Developmental medicine and child neurology 2010-11, Vol.52 (11), p.1038-1042
Hauptverfasser:	SCHEFFER, ARTHUR RT, ERASMUS, CORRIE, VAN HULST, KAREN, VAN LIMBEEK, JACQUES, ROTTEVEEL, JAN J, JONGERIUS, PETER H, VAN DEN HOOGEN, FRANK JA
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Botulinum Toxins, Type A - pharmacology Botulinum Toxins, Type A - therapeutic use Child Cohort Studies Female Humans Male Multivariate Analysis Neurotoxins - pharmacology Neurotoxins - therapeutic use Retrospective Studies Severity of Illness Index Sialorrhea - drug therapy Sialorrhea - surgery Submandibular Gland - drug effects Submandibular Gland - surgery Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!